⌕
Johnson & Johnson · JNJ · NYSE
Tenet 48 · Mixed
Compare
$282.55−1.12%At closeTenet 48 · Mixed
$282.55−3.20 (−1.12%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD
$282.70+0.15 (+0.05%)
After hours: Nov 16, 2026, 6:02 PM ET

Johnson & Johnson (JNJ) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineSteady: revenue compounds ~4.6%/yr (FY21→FY25), net margin 28.5%; free cash flow runs at 73% of net income. Check the accrual gap.
The four lines that matter · FY21–FY25
Revenue ($B)▲6.0%
94.2
FY21→FY25CAGR +4.6%/yr
Net income ($B)▲90.6%
26.8
one-off year: see footnoteCAGR +6.4%/yr
Free cash flow ($B)▼0.7%
19.7
FY21→FY25CAGR −0.1%/yr
Diluted EPS▲90.5%
11.03
buyback-liftedCAGR +9.0%/yr
What the receipts whisper · what a headline number hides
Share count
−9.1%

2.7bn → 2.4bn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.

Capex
$4.8B

steady at 5.1% of revenue (+9.2% YoY).

Returns vs FCF
93%

$18.3B returned vs $19.7B of FCF in FY25. Buybacks + dividends covered by cash flow.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($B)94.2Revenue−30.3COGS63.9Gross profit−14.7R&D−23.7SG&A25.3Op income1.5Tax & other26.8Net income

28¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
806040200%sector median net margin ~4%FY21FY25

Over this window: gross 70.3% → 67.9%. Net margin 28.5% is more than double the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
99,335.094,193.088,821.085,159.079,990.078,740.0▲6.0%+4.6%
Cost of revenue
32,222.030,256.027,471.026,553.024,596.023,402.0▲10.1%+6.6%
Gross profit
67,113.063,937.061,350.058,606.055,394.055,338.0▲4.2%+3.7%
Research & development
16,540.014,746.017,443.015,398.014,918.015,177.0▼15.5%−0.7%
Selling, general & admin
25,504.023,676.022,869.021,512.020,246.020,118.0▲3.5%+4.2%
Total operating expenses
42,375.038,650.040,546.037,399.035,439.035,504.0▼4.7%+2.1%
Operating incomefeeds ROC rank
24,738.025,287.020,804.021,207.019,955.019,834.0▲21.5%+6.3%
Other income, net
−7,001.07,294.0−4,117.0−6,145.0−596.0−656.0——
Pretax income
17,737.032,581.016,687.015,062.019,359.019,178.0▲95.2%+14.2%
Income tax
1,642.05,777.02,621.01,736.02,989.01,377.0▲120.4%+43.1%
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings
16,095.026,804.014,066.035,153.017,941.020,878.0▲90.6%+6.4%
Per share
Diluted EPSbuyback-sensitive
6.5811.035.7913.726.737.81▲90.5%+9.0%
Diluted shares (bn)
2.452.432.432.562.662.67▲0.0%−2.4%
Margins
Gross margin51st pct in Healthcare
67.6%67.9%69.1%68.8%69.3%70.3%▼1.2pp−2.4pp
Operating margin
24.9%26.8%23.4%24.9%24.9%25.2%▲3.4pp+1.7pp
Net margin79th pct in Healthcare
16.2%28.5%15.8%41.3%22.4%26.5%▲12.6pp+1.9pp
† TTM = trailing four quarters through 2026-09-27.FY21 effective tax rate was 7% vs a 15% norm for this window, likely a one-time item; see the filing.
FY07 – FY20 · 14 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium, and 14 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-11 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Johnson & Johnson's revenue last fiscal year?

Johnson & Johnson reported revenue of $94.2B in fiscal 2025, up 6.0% from fiscal 2024.

What was Johnson & Johnson's net income?

Johnson & Johnson reported net income of $26.8B in fiscal 2025, a net margin of 28.5%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.